AKBA

Akebia Therapeutics Inc

Jun 12 • 01:59PM ET

0.9207

+0.0213 2.37 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Micro • NASD

Peers: KNSA BHC PRGO ALKS AMRX INDV LNTH TEVA VTRS TLX

| Held by: VTI XBI IWM VXF VTWO IWN FESM SCHA VHT IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.08	Insider Own	2.71%	Shs Outstand	267.90M	Perf Week	-1.56%
Market Cap	246.98M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-7.37%	Shs Float	260.99M	Perf Month	-21.97%
Enterprise Value	300.55M	PEG	-	EPS next Q	-0.04	Inst Own	39.52%	Short Float	10.51%	Perf Quarter	-36.94%
Income	-20.51M	P/S	1.06	EPS this Y	-620.00%	Inst Trans	-6.84%	Short Ratio	7.10	Perf Half Y	-43.52%
Sales	232.40M	P/B	9.01	EPS next Y	-62.50%	ROA	-6.10%	Short Interest	27.42M	Perf YTD	-42.81%
Book/sh	0.10	P/C	1.50	EPS next 5Y	-	ROE	-78.96%	52W High	4.08 -77.43%	Perf Year	-74.78%
Cash/sh	0.61	P/FCF	4.11	EPS past 3/5Y	65.70% 62.40%	ROIC	-11.06%	52W Low	0.82 11.91%	Perf 3Y	-26.93%
Dividend Est.	-	EV/EBITDA	45.75	Sales past 3/5Y	-6.88% -4.37%	Gross Margin	80.46%	Volatility	9.43% 7.65%	Perf 5Y	-74.91%
Dividend TTM	-	EV/Sales	1.29	EPS Y/Y TTM	64.06%	Oper. Margin	2.28%	ATR (14)	0.08	Perf 10Y	-89.00%
Dividend Ex-Date	-	Quick Ratio	1.33	Sales Y/Y TTM	25.69%	Profit Margin	-8.83%	RSI (14)	36.12	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.40	EPS Q/Q	-233.99%	SMA20	-5.74%	Beta	0.29	Target Price	4.20
Payout	-	Debt/Eq	7.96	Sales Q/Q	-6.61%	SMA50	-24.16%	Rel Volume	1.17	Prev Close	0.90
Employees	194	LT Debt/Eq	5.77	Earnings	May 07 BMO	SMA200	-47.39%	Avg Volume	3.86M	Price	0.92
IPO	Mar 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-7.14% 3.63%	Trades		Volume	3,183,735	Change	2.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)